Acrofacial dysostosis, Kennedy-Teebi type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:64542Q75.4
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acrofacial dysostosis, Kennedy-Teebi type is a very rare genetic condition that affects the development of bones in the face and the hands and feet. 'Acrofacial' means it involves both the face (facial) and the limbs (acro = extremities), and 'dysostosis' means the bones did not form in the typical way. This condition was first described by the researchers Kennedy and Teebi, whose names it carries. People with this condition are typically born with distinctive facial features, including underdevelopment of the cheekbones and the lower jaw, as well as abnormalities of the outer ears. The hands and feet may also show differences, such as small or missing fingers or toes, or fingers that are fused together. These features are present from birth. Because this condition is extremely rare, treatment is focused on managing individual symptoms rather than curing the underlying cause. A team of specialists — including craniofacial surgeons, ear specialists, and hand surgeons — typically work together to help improve function and appearance. Early intervention and supportive therapies can make a meaningful difference in quality of life.

Also known as:

Key symptoms:

Underdeveloped or small cheekbonesSmall or underdeveloped lower jawAbnormally shaped or small outer earsHearing loss due to ear abnormalitiesMissing, small, or fused fingers or toesUnderdeveloped or absent thumbsShort statureDownward-slanting eye openingsCleft palate or high-arched palate in some casesWidely spaced eyes

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Acrofacial dysostosis, Kennedy-Teebi type.

View clinical trials →

No actively recruiting trials found for Acrofacial dysostosis, Kennedy-Teebi type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Acrofacial dysostosis, Kennedy-Teebi type community →

No specialists are currently listed for Acrofacial dysostosis, Kennedy-Teebi type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acrofacial dysostosis, Kennedy-Teebi type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acrofacial dysostosis, Kennedy-Teebi typeForum →

No community posts yet. Be the first to share your experience with Acrofacial dysostosis, Kennedy-Teebi type.

Start the conversation →

Latest news about Acrofacial dysostosis, Kennedy-Teebi type

No recent news articles for Acrofacial dysostosis, Kennedy-Teebi type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What genetic tests should we do to confirm the diagnosis and find the specific gene change?,Does my child need any urgent treatment for breathing or feeding right now?,What specialists should be part of my child's care team, and how often should we see each one?,When and what type of surgeries might be recommended as my child grows?,How can we best support my child's hearing and speech development?,What are the chances that other family members or future children could be affected?,Are there any patient registries or research studies we could participate in to help advance understanding of this condition?

Common questions about Acrofacial dysostosis, Kennedy-Teebi type

What is Acrofacial dysostosis, Kennedy-Teebi type?

Acrofacial dysostosis, Kennedy-Teebi type is a very rare genetic condition that affects the development of bones in the face and the hands and feet. 'Acrofacial' means it involves both the face (facial) and the limbs (acro = extremities), and 'dysostosis' means the bones did not form in the typical way. This condition was first described by the researchers Kennedy and Teebi, whose names it carries. People with this condition are typically born with distinctive facial features, including underdevelopment of the cheekbones and the lower jaw, as well as abnormalities of the outer ears. The hands

How is Acrofacial dysostosis, Kennedy-Teebi type inherited?

Acrofacial dysostosis, Kennedy-Teebi type follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Acrofacial dysostosis, Kennedy-Teebi type typically begin?

Typical onset of Acrofacial dysostosis, Kennedy-Teebi type is neonatal. Age of onset can vary across affected individuals.